Microparticles in cardiovascular disease pathophysiology and outcomes
Authors:
- Anthony J. VieraAVAnthony J. Viera
- Micah MooberryMMMicah Mooberry
- Nigel S. KeyNKNigel S. Key
- 1 July 2012
- journal article
- review article
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 6 (4) , 243-252
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Microparticles, Vascular Function, and AtherothrombosisCirculation Research, 2011
- Microparticles: Key Protagonists in Cardiovascular DisordersSeminars in Thrombosis and Hemostasis, 2010
- Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosisJournal of Thrombosis and Haemostasis, 2010
- Microparticles, vascular function and hypertensionCurrent Opinion in Nephrology and Hypertension, 2010
- Elevated circulating endothelial microparticles and brachial–ankle pulse wave velocity in well-controlled hypertensive patientsJournal of Human Hypertension, 2008
- In Vivo Shear Stress Determines Circulating Levels of Endothelial Microparticles in End-Stage Renal DiseaseHypertension, 2007
- Circulating Endothelial Microparticles Are Associated with Vascular Dysfunction in Patients with End-Stage Renal FailureJournal of the American Society of Nephrology, 2005
- Cellular microparticles: new players in the field of vascular disease?European Journal of Clinical Investigation, 2004
- High levels of circulating endothelial microparticles in patients with acute coronary syndromesAmerican Heart Journal, 2003
- Effects of Severe Hypertension on Endothelial and Platelet MicroparticlesHypertension, 2003